Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Revenue: 2016-2024

Historic Revenue for Autolus Therapeutics (AUTL) over the last 9 years, with Dec 2024 value amounting to $10.1 million.

  • Autolus Therapeutics' Revenue rose 298.33% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.1 million, marking a year-over-year increase of 225.04%. This contributed to the annual value of $10.1 million for FY2024, which is 496.00% up from last year.
  • Autolus Therapeutics' Revenue amounted to $10.1 million in FY2024, which was up 496.00% from $1.7 million recorded in FY2023.
  • In the past 5 years, Autolus Therapeutics' Revenue registered a high of $10.1 million during FY2024, and its lowest value of $1.5 million during FY2020.
  • Its 3-year average for Revenue is $6.0 million, with a median of $6.2 million in 2022.
  • Its Revenue has fluctuated over the past 5 years, first slumped by 72.59% in 2023, then skyrocketed by 496.00% in 2024.
  • Over the past 5 years, Autolus Therapeutics' Revenue (Yearly) stood at $1.5 million in 2020, then rose by 2.31% to $1.5 million in 2021, then surged by 311.02% to $6.2 million in 2022, then plummeted by 72.59% to $1.7 million in 2023, then spiked by 496.00% to $10.1 million in 2024.